- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07801872
Assessment of Six-minute Walking Distance 6MWD Between High Altitude HA vs. Sea Level LA in Healthy Individuals H
31 agosto 2026 aggiornato da: Silvia Ulrich Somaini
Effect of a One-week Descent From 2850m to Sea Level and Re-ascent in Patients With Pulmonary Arterial Hypertension and Healthy Controls Permanently Living > 2600m on Pulmonary Hemodynamics, Exercise Capacity, Blood Oxygenation, Sleep Disordered Breathing and Further Outcomes
To study the effect of descent from high altitude (Quito Ecuador: 2850m) to sea level on six-minute walking distance and scores in healthy individuals, who live permanently >2600m.
Panoramica dello studio
Stato
Non ancora reclutamento
Intervento / Trattamento
Descrizione dettagliata
The aim of this research is to investigate the six-minute walking distance and scores before and after descent (high altitude near their living altitude vs. sea level) in healthy individuals, who permanently live at high altitude over 2600m.
Tipo di studio
Interventistico
Iscrizione (Stimato)
14
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Contatto studio
- Nome: Silvia Ulrich, Prof. Dr. med.
- Numero di telefono: +41442552220
- Email: silvia.ulrich@usz.ch
Backup dei contatti dello studio
- Nome: Michael Furian, Prof. Dr. sc. ETH
- Numero di telefono: +41442552220
Luoghi di studio
-
-
-
Zurich, Svizzera, 8091
- University Hospital of Zurich
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Sì
Descrizione
Inclusion Criteria:
- Adults aged 18-80 years and of all genders
- Permanent residence > 2600 m
- healthy: no self-perceived cardiopulmonary disease limiting daily activities
- written informed consent to participate in the study
Exclusion Criteria:
- Age <18 years or >80 years
- Participants who cannot follow the study investigations
- Participants permanently living < 2600m
- Participants who traveled and stayed overnight at altitudes <2000 m in the past 4 weeks.
- any self-perceived cardiopulmonary disease limiting daily activities
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Six-minute walking distance 6MWD at sea level
Assessment of the six-minute walking distance and scores near their resident altitude at 2850m followed by a descent from 2850m to sea level by bus with a stay for 7 days and again assessment of the same outcomes
|
Descent from 2850m to sea level with stay for 7 days
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Six-minute walking distance after 7 days at sea level
Lasso di tempo: From high altitude (2850m) to day 5-7 at sea level
|
Difference/change in six-minute walking distance in meter (6MWD) between 2850m and Day 5-7 at sea level in healthy individuals
|
From high altitude (2850m) to day 5-7 at sea level
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
SpO2 (%) at rest and end-exercise after 7 days at sea level
Lasso di tempo: From high altitude (2850m) to day 5-7 at sea level
|
Difference/change in SpO2 (peripheral oxygen saturation) at rest and end-exercise between 2850m and Day 5-7 at sea level in healthy individuals
|
From high altitude (2850m) to day 5-7 at sea level
|
|
Heart rate (beats per minute) at rest and end-exercise after 7 days at sea level
Lasso di tempo: From high altitude (2850m) to day 5-7 at sea level
|
Difference/change in heart rate at rest and end-exercise between 2850m and Day 5-7 at sea level in healthy individuals
|
From high altitude (2850m) to day 5-7 at sea level
|
|
Blood pressure (mmHg) at rest and end-exercise after 7 days at sea level
Lasso di tempo: From high altitude (2850m) to day 5-7 at sea level
|
Difference/change in blood pressure at rest and end-exercise between 2850m and Day 5-7 at sea level in healthy individuals
|
From high altitude (2850m) to day 5-7 at sea level
|
|
Dyspnea and leg discomfort sensation after 7 days at sea level
Lasso di tempo: From high altitude (2850m) to day 5-7 at sea level
|
Difference/change in dyspnea and leg discomfort sensation (assessed with BORG-CR10-Scale, Category Rating 0-10 with 10 being the most dyspnea/leg discomfort) at rest and end-exercise between 2850m and 5-7 days at sea level in healthy individuals
|
From high altitude (2850m) to day 5-7 at sea level
|
|
NYHA functional class (1-4) after 7 days at sea level
Lasso di tempo: From high altitude (2850m) to day 5-7 at sea level
|
Difference/change in NYHA functional class (New York Heart Association Class I-IV, IV being the worst) at rest and end-exercise between 2850m and 5-7 days at sea level in healthy individuals
|
From high altitude (2850m) to day 5-7 at sea level
|
|
Quality of life after 7 days at sea level
Lasso di tempo: From high altitude (2850m) to day 5-7 at sea level
|
Difference/change in quality of life score (EmPHasis-10: Score with 10 questions and 0-50 points, higher scores indicating poorer quality of life) between 2850m and 5-7 days at sea level in healthy individuals
|
From high altitude (2850m) to day 5-7 at sea level
|
|
General well-being after 7 days at sea level
Lasso di tempo: From high altitude (2850m) to Day 5-7 at sea level
|
Difference/change in general well-being (Visual Analog Scale 10cm: the higher, the worse) between 2850m and day 5-7 at sea level in healthy individuals
|
From high altitude (2850m) to Day 5-7 at sea level
|
|
Acclimatization-effect of six-minute walking distance (m) at sea level
Lasso di tempo: From Day 2 to Day 5-7 at sea level
|
Difference/change in six-minute walking distance (6MWD) within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
|
From Day 2 to Day 5-7 at sea level
|
|
Acclimatization-Effect of SpO2 (%) at rest and end-exercise at sea level
Lasso di tempo: From Day 2 to Day 5-7 at sea level
|
Difference/change in SpO2 (peripheral oxygen saturation) at rest and end-exercise within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
|
From Day 2 to Day 5-7 at sea level
|
|
Acclimatization-Effect of heart rate (beats per minute) at rest and end-exercise at sea level
Lasso di tempo: From Day 2 to Day 5-7 at sea level
|
Difference/change in heart rate at rest and end-exercise within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
|
From Day 2 to Day 5-7 at sea level
|
|
Acclimatization-Effect of blood pressure (mmHg) at rest and end-exercise at sea level
Lasso di tempo: From Day 2 to Day 5-7 at sea level
|
Difference/change in blood pressure at rest and end-exercise within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
|
From Day 2 to Day 5-7 at sea level
|
|
Acclimatization-Effect of dyspnea and leg discomfort at sea level
Lasso di tempo: From Day 2 to Day 5-7 at sea level
|
Difference/change in dyspnea and leg discomfort (assessed with BORG-CR10-Scale, Category Rating 0-10 with 10 being the most dyspnea/leg discomfort) at rest and end-exercise within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
|
From Day 2 to Day 5-7 at sea level
|
|
Acclimatization-Effect of NYHA functional class (1-4) at sea level
Lasso di tempo: From Day 2 to Day 5-7 at sea level
|
Difference/change in NYHA functional class (New York Heart Association Class I-IV, IV being the worst) at rest and end-exercise within a stay of 7 days at sea level (after descent from 2850m) in healthy individuals
|
From Day 2 to Day 5-7 at sea level
|
|
Acclimatization-Effect of Quality of Life at sea level
Lasso di tempo: From Day 2 to Day 5-7 at sea level
|
Difference/change in quality of life (EmPHasis-10: Score with 10 questions and 0-50 points, higher scores indicating poorer quality of life) within a stay of 7 days at sea level (after descent from 2850m) in healthy individuals
|
From Day 2 to Day 5-7 at sea level
|
|
Acclimatization-Effect of general well-being at sea level
Lasso di tempo: From Day 2 to Day 5-7 at sea level
|
Difference/change in general well-being (Visual Analog Scale 10cm: the higher, the worse) within a stay of 7 days at sea level (after descent from 2850m) in healthy individuals
|
From Day 2 to Day 5-7 at sea level
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Investigatori
- Investigatore principale: Silvia Ulrich, University Hospital Zurich, Departement of Pulmonology
- Investigatore principale: Rodrigo Hoyos, Hospital Carlos Andrade Marin of Quito, Ecuador
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Stimato)
25 settembre 2026
Completamento primario (Stimato)
4 ottobre 2026
Completamento dello studio (Stimato)
31 dicembre 2026
Date di iscrizione allo studio
Primo inviato
17 agosto 2026
Primo inviato che soddisfa i criteri di controllo qualità
31 agosto 2026
Primo Inserito (Effettivo)
3 settembre 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
3 settembre 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
31 agosto 2026
Ultimo verificato
1 agosto 2026
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- Ec_HAvsLA_6MWD_H
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
SÌ
Descrizione del piano IPD
Data will be provided upon request and based on a clear intention reviewed by an ethical review board.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .